Spero Therapeutics, Inc. (SPRO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 130.53M |
| Enterprise Value | 93.16M |
| P/E Ratio | 8.71 |
| PEG Ratio | 0.06 |
| Price/Sales Ratio | 1.64 |
| Price/Book Ratio | 1.6 |
| Enterprise/Revenue | 0.51 |
| Enterprise/EBITDA | 2.85 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.17 |
| Operating Margin | 0.14 |
| Return On Assets | 0.14 |
| Return On Equity | 0.16 |
| Revenue | 59.62M |
| Revenue/Share | 0.74 |
| Gross Profit | 59.62M |
| EBITDA | 8.83M |
| Net Income | 8.57M |
| Diluted EPS | 0.15 |
| Total Cash | 50.77M |
| Total Cash/Share | 0.88 |
| Total Debt | 2.04M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 6.12 |
| Book Value Per Share | 0.76 |
| 52-Week Change | -34.05 |
| 52-Week High | 3.08 |
| 52-Week Low | 1.08 |
| Moving Average 50 Days | 1.71 |
| Moving Average 200 Days | 2.28 |
| Average Volume | 1.61M |
| Shares Outstanding | 57.9M |
| % Held by Institutions | 36.04 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |